Skip to Content

17th Annual Interdisciplinary Conference on Supportive Care, Hospice and Palliative Medicine

October 11-12, 2013

The University of Texas MD Anderson Cancer Center
Main Building, Hickey Auditorium, Floor 11
1515 Holcombe Boulevard, Houston, TX 77030

General Information

 Goal 

Identify the moral and ethical dilemmas facing clinicians who provide End-of-Life care; Practice state-of-the art pain and symptom management for patients with advanced disease; Demonstrate effective communication with patients in advanced stages of cancer or debilitating disease and provide quality end of life care; and exhibit heightened awareness of medical, legal and spiritual issues facing patients and families involved in the care of advanced disease.

Educational Objectives

After attending the conference, participants should be able to:

  • identify and interpret the moral and ethical dilemmas encountered in palliative care, incorporating supportive care strategies to improve patient care (knowledge, competence, performance, patient outcomes);
  • interpret medical, legal and spiritual issues facing physicians and the healthcare team involved in care of advanced disease (knowledge, competence); 
  • demonstrate effective communication with patients in the advanced stages of cancer or debilitating disease and provide quality End-of-Life care (knowledge, competence, performance);
  • utilize state of the art pain and symptom management for patients with advanced disease (knowledge, competence, performance, patient outcomes).

Target Audience

This program should be of interest to palliative care or hospice physicians, oncologists, internal medicine physicians, family practice physicians, psychiatrists, and/or anesthesiologists.  Other professionals including: hospice, nursing, psychology,
chaplaincy, ethics, and/or sociology.

Educational Methods

• Lectures• Workshop Sessions• Case Studies

Evaluation

A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the
opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Accreditation/Credit Designation

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this educational activity for a maximum of 15.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Ethics

This course has been designated by The University of Texas MD Anderson Cancer Center for 14.75 AMA PRA Category 1 Credits™  in medical ethics and/or professional responsibility.  

Nursing

The University of Texas MD Anderson Cancer Center is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Nursing Continuing Education Contact Hours will be awarded.

CME Certificates and Attendance Verification Certificates

Certificates awarding AMA PRA Category 1 Credits™ or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form. Upon receipt, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

Photographing, audio taping and videotaping are prohibited.

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented.  MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products.  Specific disclosure will be made to the participants prior to the educational activity.  

Agendas are subject to change because we are always striving to improve the quality of your educational experience.  MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.


© 2013 The University of Texas MD Anderson Cancer Center